← Back to Search

Other

Palliative Care + Digital Symptom Monitoring for Acute Myeloid Leukemia

N/A

Recruiting

Led By Gabriel Mannis, MD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, and 6 months

Awards & highlights

Study Summary

This trial is studying a new way to provide care for people with AML that uses video conferencing and digital symptom monitoring. They want to see if this is a feasible way to provide care, if it improves patients' quality of life, and how patients experience this care.

Who is the study for?

This trial is for patients with newly diagnosed acute myeloid leukemia at Stanford Cancer Center, who can use a digital symptom tracking app and are able to perform limited self-care. They should be starting low-intensity therapy that doesn't need hospitalization and have an estimated life expectancy of at least 6 months.Check my eligibility

What is being tested?

The study tests the feasibility of telehealth palliative care combined with digital symptom monitoring in AML patients undergoing low-intensity therapy. It aims to see if this approach is practical, improves quality-of-life metrics, and affects advance care planning and hospital utilization.See study design

What are the potential side effects?

Since the intervention involves non-medical services (telehealth palliative care and digital monitoring), traditional medication side effects aren't expected. However, participants may experience emotional or psychological impacts from discussing their condition.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 months, and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 months, and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of completed palliative care referrals and monthly visits

Rate of usage of digital symptom monitoring application, Noona

Secondary outcome measures

Mean change in Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu) scores

Mean change in Hospital Anxiety and Depression Scale (HADS) scores

Mean change in Patient Health Questionnaire (PHQ)-9 scores

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: All patientsExperimental Treatment1 Intervention

All patients enrolled in this trial will be referred to palliative care for planned monthly virtual visits, be instructed on the use of a digital application Noona that can be downloaded on their personal electronic device, and will be prompted to fill out symptom questionnaires using Noona prior to palliative care visits (required) as well as weekly (optional).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,395 Previous Clinical Trials

17,341,580 Total Patients Enrolled

Varian Medical Systems, Inc.UNKNOWN

1 Previous Clinical Trials

152 Total Patients Enrolled

Gabriel Mannis, MDPrincipal InvestigatorStanford University

Media Library

Palliative Care + Digital Symptom Monitoring (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04885127 — N/A

Acute Myeloid Leukemia Research Study Groups: All patients

Acute Myeloid Leukemia Clinical Trial 2023: Palliative Care + Digital Symptom Monitoring Highlights & Side Effects. Trial Name: NCT04885127 — N/A

Palliative Care + Digital Symptom Monitoring (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04885127 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary purpose of this clinical research endeavor?

"The primary aim of this 6-month clinical trial is to assess the rate at which patients use digital symptom monitoring app Noona. Additionally, the study will evaluate overall satisfaction with using Noona (via qualitative survey responses), along with a change in scores on Hospital Anxiety and Depression Scale (HADS) and Patient Health Questionnaire-9 (PHQ-9). The maximum score for both these surveys are 42 and 27 respectively; higher scores indicate increased anxiety/depression or worse mood."

Answered by AI

How many individuals are engaging in this medical research?

"Indeed, records from clinicaltrials.gov suggest that recruitment for this medical trial is ongoing. The project was originally uploaded on March 30th 2022 and most recently updated on April 4th of the same year. Forty patients are required to be selected at a single site."

Answered by AI

Does this scientific experiment currently have open enrollment?

"Affirmative. According to clinicaltrials.gov, this medical research project is presently enrolling candidates after being published on March 30th 2022 and updated most recently on April 4th 2022. This study calls for 40 participants at a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia

Gabriel Mannis 2022. "Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04885127.